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Available online 15 October 2016Objective: A potential mechanism by which obesity could promote hypertension and kidney diseases is through
accumulation of adipose tissue in the renal sinus (RS). The aim of the study was to quantify RS and abdominal
adipose tissue volumes and to evaluate serum kidney injury molecule (sKIM)-1 and ﬁbroblast growth factor
(FGF)-21 association with different adipose tissue compartments.
Methods: The cross-sectional study included 280 and follow-up study-40 asymptomatic participants; aged
38.30 ± 4.10. For all study participants computed tomography examination was performed, sKIM-1 and FGF-
21 levels were measured.
Results: The results indicated asymmetrical deposition of adipose tissue into the RS even after corresponding kid-
ney volume adjustment. The cross-sectional and the follow-up studies showed that sKIM-1 level was positively
associated with RS adipose tissue volume increase for both genders. FGF-21 was positively associated with RS
and retroperitoneal adipose tissue amount.
Conclusions:Regardless of gender adipose tissue in RS accumulates asymmetrically–the left RS accumulates a sig-
niﬁcantly higher amount of adipose tissue. Thus, primarily RS adipose tissue effects should be assessed on the left
kidney. Accumulation of adipose tissue in the RS is related with the visceral adipose amount, KIM-1 and FGF-21
concentration increase in the blood serum.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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In humans and most animal models, development of obesity also
leads to ectopic adipose tissue storage (Bjorndal et al., 2011). Normal
renal sinus (RS) contains a small amount of adipose tissue that lines
other structures within it. By excess deposition of perirenal adipose tis-
sue in the RS, compression of various renal structures may occur, espe-
cially the inner medulla that, unlike the entire kidney, is not protected
by the ﬁbrous capsule (Lamacchia et al., 2011). It has been previously
shown that RS adipose tissue may have an independent association
with renal functions (Chughtai et al., 2010; Foster et al., 2011b). Howev-
er, RS adipose tissue research is limited to only a couple of recently pub-
lished studies. Foster et al. (Foster et al., 2011b) showed that RS adipose
tissue is associated with an increased risk of hypertension and chronic
renal disease. Similarly, Chughtai et al. (Chughtai et al., 2010) indicated. This is an open access article underthat RS adipose tissue volume was associated with the number of pre-
scribed antihypertensive medications and stage II hypertension.
Overall, obesity can lead to renal functional disorders and induce hy-
pertension through a variety of mechanisms: (Hall, 1997; Hall et al.,
1999; Hall et al., 2002; Hall et al., 2010; Hall et al., 2015; Hall et al.,
2014). Activation of sympathetic nervous system; Physical–mechanical
compression; Renin–angiotensin–aldosterone system. It has been hy-
pothesized that RS adipose tissue effect is local and mostly occurs
through the physical–mechanical compression (Montani et al., 2004;
Hall et al., 2014). However, unfortunately exactmechanismshowRS ad-
ipose tissue could inﬂuence kidney functions are not described. Addi-
tionally, published RS adipose tissue research has some signiﬁcant
disadvantages. Since the object segmentation and 3D reconstruction of
organs is labor-intensive and time-consuming, often chosen strategy is
computed tomography (CT) or magnetic resonance (MR) single-scan
measurement at a speciﬁc anatomic level. In this way, the manual
data processing is reduced signiﬁcantly. However, as the RS adipose tis-
sue is a small and diffuse object, this also results in loss of the measure-
ment quality. Since RS adipose tissue compartment is relatively smallthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Design of the cross-sectional and the prospective one-year naturalistic follow-up
study.
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sue and analyze it's full volumes, was used, thus more accurately char-
acterizing RS adipose tissue and it's role.
In our study we analyze asymptomatic, middle age participants,
therefore, it was important to ﬁnd an earlier diagnostic biomarkers of
kidney injury. It is useful to keep in mind that creatinine level may not
raise until more than half of the kidney function has been lost due to
renal reserve. Kidney injury factor (KIM)-1 serves as an earlier diagnos-
tic biomarker of kidney injury when compared to any of the conven-
tional diagnostic markers, e.g., serum creatinine and cystatin C,
increased proteinuria. It has been approved by the US Food and Drug
Administration as an acute kidney injury biomarker for preclinical
drug development (Dieterle et al., 2010). KIM-1 expression and secre-
tion was observed in the kidney epithelial cells in vitro (Ichimura et
al., 2004), in animalmodels and in patientswith various kidney diseases
(Lim and Meigs, 2013). Experiments in rodents and studies in humans
have shown that kidney ischemia or hypoxia promotes KIM-1 concen-
trations increase in the urine and blood serum. Chronic KIM-1 expres-
sion can promote further tubulointestinal inﬂammation and hypoxia,
further inducing KIM-1 expression that culminate in chronic kidney dis-
ease (Humphreys et al., 2013). The ectodomain of KIM-1 is shed into the
lumen, and serves as a urinary biomarker of kidney injury (Bonventre,
2009; Kuwata et al., 2015; Jin et al., 2013). Recent study showed that
KIM-1 may be released into the circulation and identiﬁed KIM-1 as a
blood biomarker that speciﬁcally reﬂects injury to the proximal tubule
of the kidney, the primary site of injury for ischemia and most
nephrotoxicants (Sabbisetti et al., 2014; Bonventre et al., 2010). The
proposed mechanisms for the KIM-1 reabsorption are: (1) After kidney
proximal tubule injury when tubular cell polarity is lost and KIM-1may
be released directly into the interstitium; (2) Renalmicrovascular endo-
thelial cells are detached from the basement membrane that facilitate
KIM-1 reabsorption into the circulation (Sabbisetti et al., 2014) (Hall
et al., 2014).
Recently, ﬁbroblast growth factor (FGF)-21 was introduced as a
renal function marker. FGF-21 levels were higher in the patients with
both chronic and acute renal dysfunctions. Additionally, FGF-21 levels
gradually increased with the development or renal diseases from the
early to late stage (Zhang et al., 2015). FGF-21 serve as renal function
marker because renal elimination is a major route by which physiolog-
ical FGF-21 serum levels are maintained (Stein et al., 2009). Respective-
ly, if renal function is impaired, serum FGF-21 level rise.
In general, there is limited information about the mechanism how
RS adipose tissue induce renal disease and hypertension. There is no in-
formation about RS adipose tissue and early diagnostic biomarkers of
kidney injury. Additionally, all previously conducted researches were
based on RS adipose tissue single slice measurements. Thereby, the
aim of the study was to quantify RS and abdominal adipose tissue vol-
umes and to evaluate sKIM-1 (as primary kidneys damage marker)
and FGF-21 association with different adipose tissue compartments in
the observational study with a cross-sectional design and a prospective
one-year naturalistic follow-up study.We hypothesized that RS adipose
tissue would be independently associated with sKIM-1 and FGF-21
levels after accounting for abdominal adipose tissue segments (retro-
peritoneal (RP), intraperitoneal (IP) and subcutaneous (SC)) as a mea-
sure of abdominal obesity.
2. Methods
2.1. Participants and Study Design
An observational study with a cross-sectional design and a prospec-
tive one-year naturalistic follow-up study. The period of recruitment
was from January 2011 till January 2014. The sample sizewas calculated
according to proportions (n=1.962 ×4p(1−p)/d2;where: p – expect-
ed population proportion; d - the desiredwidth of the conﬁdence inter-
val (CI)). In our case: an estimate of the prevalence of adipose tissueaccumulation in the RS is 0.99 (99%). The width of the 95% CI is 0.1. Es-
timated minimal sample size was 153 subjects.
The cross-sectional study participants were selected from family
physician's practices of a Health care center in Riga. The exclusion
criteria for the participants selection were a recorded diagnosis of
chronic kidney diseases (nephrolithiasis; renal cysts; nephroptosis;
an extra kidney; renal lipomatosis), cardiovascular diseases, thyroid dis-
eases, diabetes or malignancy; use of tobacco and alcohol (male N140 g
ethanol per week; female N70 g ethanol per week); anamnesis of
arterial hypertension, pregnancy and lactation, taking any regular
medications; body mass index (BMI) b 18 kg/m2 and BMI N 35 kg/m2.
The inclusion criteria were BMI = 18–35 kg/m2, age 30–45 years.
In the cross-sectional study 280 participants were recruited (144/136,
F/M) aged 37.30 ± 4.10 years, ethnicity – Caucasians.
Participants (n= 40; 20/20, F/M) for the prospective one-year nat-
uralistic follow-up study were recruited from the cross-sectional study
group. The inclusion criteria for this study were left RS ratio N 0.025
(see Section 2.3). The participants were randomized into two groups:
participants (10/10, F/M) randomized for the intervention received
daily text messages for one year. Text messages included practical rec-
ommendations on how to balance caloric intake and physical activity
to achieve and maintain a healthy body weight. The recommendations
were prepared by the general practitioner according to the diet and life-
style recommendations (Eckel et al., 2014). Other randomized 10males
and 10 females did not receive any intervention for one year. The study
design is shown in the Fig. 1.
Experimental procedures were approved by the Ethical Committee
of the Institute of Experimental and Clinical Medicine, University of
Latvia. All procedures performed in this study were in accordance
with the ethical standards of the institutional and international research
committee and with the 1964 Helsinki declaration. Informed consent
was obtained from all study participants.
2.2. Anthropometric Parameters
BMI was calculated as the ratio of weight to height squared. Normal
weightwas deﬁned as BMI 18.0–24.9 kg/m2; overweight – as BMI 25.0–
29.9 kg/m2 and obesity – as BMI ≥ 30 kg/m2. Waist circumference (WC)
wasmeasured using a tape rule, and the point of measurement was the
anterior superior iliac spine (Kovesdy et al., 2010). Blood pressure (sys-
tolic blood pressure (SBP) and diastolic blood pressure (DBP))measure-
ments were performed by professional medical assistant.
2.3. Abdominal and RS Adipose Tissue Quantiﬁcation
Native abdominal (~Th10 to ~L4) CT scans were captured using spi-
ral (128-slice conﬁguration) CT SOMATOM Deﬁnition AS/AS (Siemens
AG, Forchheim, Germany) with automated tube current modulation
(CareDose4D, Siemens) during inspiratory breath-hold (slice thickness
276 G. Krievina et al. / EBioMedicine 13 (2016) 274–2835 mm). CT scans were post-processed using the 3D Doctor software
(Able Software Corp., Lexington, MA, USA). According to the techniques
and anatomical landmarks published previously (Chughtai et al., 2010),
abdominal adipose tissue was manually segmented into SC, RP, and IP
compartments (Fig. 2. c). Two abdominal adipose tissue measurement
series were performed. First, total abdominal adipose tissue volume
was measured at the level of both kidneys (n= 100) (Fig. 2a, A-1) for
all compartments (RPfull, IPfull, SCfull). Second, CT measurements of ab-
dominal adipose tissue was performed in three axial slices (RPthree-slices,
IP
three-slices
, SCthree-slices) (Fig. 2a, A-2) positioned at the level of the right
renal hilum. Next, total volumetric RS adipose tissue segmentation
from both kidneys were performed. According to the Foster et al.
(Foster et al., 2011a; Foster et al., 2011b) protocol, the boundary of RS
was deﬁned as a straight line between both dimples at the edge of the
RS opening (Fig. 2a, A-1). Since RS adipose tissue compartment is rela-
tively small object, strategy to segment the entire RS adipose tissue inFig. 2. Abdominal computed tomography scans demonstrating renal sinus and abdominal
measurements. A-1 – the level where total abdominal adipose tissue measurements w
measurements in three axial slices were performed (RPthree-slices, IPthree-slices, SCthree-slices). The
for RS and abdominal adipose tissue compartment measurements; c: Visualization of RS and
Volumetric right and left RS adipose tissue compartment visualization. e: Measure of the k
diameter (3.) in the axial plane; f: 3D reconstruction of RS, IP, RP, SC and kidneys. RS adipose t
level. Subcutaneous adipose tissue (SC) (gray); Intraperitoneal (IP) adipose tissue (yellow); RPthe RS and analyze its full volumeswas used, thusmore accurately char-
acterizing RS adipose tissue (Fig. 2d and f). Additionally, total volumet-
ric kidney segmentation was performed (we excluded major branches
of the renal artery and vein as well as any visible branches of the renal
collecting system) (Chughtai et al., 2010). According to Glodny et al.
(Glodny et al., 2009) a kidney length (pole to pole) in the coronal
plane and according to Breau et al. (Breau et al., 2013) sagittal and later-
al diameter in the axial plane were measured (Fig. 2e).
Overall, for adipose tissue compartments and kidney volume detec-
tion, ﬁrst, region of interest was manually outlined with the mouse by
using a tool called “Polygon” on each section. Second, segmentation of
adipose tissue and kidney volumes was performed based on Hounsﬁeld
units (HU). Adipose tissue was identiﬁed using an attenuation range of
(−195)–(−45) HU (Foster et al., 2011a; Foster et al., 2011b), for kid-
neys - (+20)–(+40) HU (Hofer, 2010). Third, we used 3D Rendering
Full Complex Surface command and constructed 3D models (Fig. 2dadipose tissue compartment measurements. a: The levels of abdominal adipose tissue
ere performed (RPfull, IPfull, SCfull). A-2 – the level where abdominal adipose tissue
red line represents the boundary of RS; b: Example of single abdominal CT slice selected
abdominal adipose tissue compartments as well as kidney using 3D Doctor software; d:
idney length (pole to pole) (1.) in the sagittal plane and sagittal (2.) as well as lateral
issue and kidneys were segmented fully; RP, IP and SC adipose tissue at the renal hilum's
adipose tissue (purple); Right RS adipose tissue (red); Left RS adipose tissue (green).
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measured by volume and surface rendering technique according to
which the 3D Doctor software calculates segmental volume of each re-
spective adipose tissue compartment slice as the product the slice area
and the inter-slice distance (slice thickness). The volume of the entire
adipose tissue compartment was then calculated as a sum of segmental
volumes as indicated by the Cavalieri's principle (Szczepaniak et al.,
2013): the volume of the abdominal or the RS adipose tissue = Σ (vol-
umes of all respective adipose tissue slices).
In order to exclude the kidney size effect on RS adipose tissue vol-
ume, ratio of RS adipose tissue volume to corresponding total kidney
size was calculated using the arithmetical mean for each participant:
left RS ratio ¼ left RS adipose tissue volume
left kidney volume
right RS ratio ¼ right RS adipose tissue volume
right kidney volume
The participants for the prospective one-year naturalistic follow-up
study were recruited from the cross-sectional study group according
to 75th percentile of the left RS ratio (75th percentile = 0.025). The
left RS ratio was chosen because the left RS accumulates signiﬁcantly
higher amount of adipose tissue compared to the right RS (see Section
3.4).
2.4. Analytical Methods
sKIM-1 level was measured by Human Kidney Toxicity Magnetic
Bead Panel 1, HKTX1MAG-38K (Millipore, Billerica, MA, USA), interleu-
kin (IL)-6 and tumor necrosis factor alpha (TNFα) were measured by
HADCYMAG-61 (Millipore, Billerica, MA, USA) on a Luminex 200 ana-
lyzer (Austin, TX, USA). FGF-21 was measured by ELISA kits
(#EZHFGF21-19K; Millipore, Billerica, MA, USA) on an Inﬁnite®M200
analyzer (Tecan Trading AG, Switzerland). The tests were performed
in accordance with the manufacturer's instructions. Serum creatinine,
cystatin C, glucose, triglycerides (TG), high density lipoprotein choles-
terol (HDLC) and low density lipoprotein cholesterol (LDLC) tests
were performed in the clinical laboratory ‘E.Gulbja laboratorija’, Riga,
Latvia. The estimated glomerular ﬁltration rate (eGFREPI cyst&crea) was
determined using cystatin C and creatinine concentrations and Chronic
Kidney Disease Epidemiology equation (Inker et al., 2012).
Venous blood samples for blood tests were collectedwithout antico-
agulant and were allowed to coagulate for 25–30min at the room tem-
perature. After that, samples were centrifuged at 4 °C for 10 min at
1600 ×g. All specimens were immediately aliquoted, frozen, and stored
at−80 °C until use (for serum sKIM-1 and FGF-21 analysis; standard
blood testswere performed using fresh serum samples). Serum samples
were obtained after an overnight fast.
2.5. Statistical analysis
For the cross-sectional study the fatty kidney group was deﬁned as
the presence of high left RS ratio based on gender speciﬁc 75th percen-
tiles (Control group b 75th percentiles). For the prospective one-year
naturalistic follow-up study we divided all (n = 40) participants in
the three groups according to the signiﬁcant (N5%) visceral adipose tis-
sue (IP adipose tissue+ RP adipose tissue) volume change after follow-
up period: Group 1 (control) – no signiﬁcant visceral adipose tissue
volume change; Group 2 - signiﬁcant visceral adipose tissue volume
decrease; Group 3 - signiﬁcant visceral adipose tissue volume increase.
Data were analyzed using SPSS22.0. After testing normality
(Kolmogorov-Smirnov test) unpaired data with normal distribution
(presented as mean ± SD) were analyzed using unpaired Student
t-test. Mann-Whitney U test was used as nonparametric method for
unpaired data (data with skewed distribution presented as medianand interquartile range). p b 0.05 was considered signiﬁcant. Paired
data (left vs. right RS ratio, left vs. right kidney and follow up study's
data (baseline vs. end)) were compared using Wilcoxon rank-sum
test. Square root transformation (sqrt) was used for positive skew
data, when Pearson and age and gender adjusted partial Pearson correla-
tions as well as multiple linear regression analysis were performed.
Pearson correlation was used to detect association between different
abdominal and RS adipose tissue compartments. Associations between
sKIM-1 or FGF-21 and different adipose tissue compartments were
assessed by an age and gender adjusted stepwise-methodmultiple linear
regression analysis (results presented as standardized regression coefﬁ-
cient (β); 95% CI; R2% and p value). Collinearity was assessed using vari-
ance inﬂation factor (VIFs) and tolerance (VIF N 10.0 and tolerance b 0.2
indicatingmodel instability). Binary logistic regressionwas used to calcu-
late age and gender adjusted p values. All adipose tissue compartments
were measured separately by two readers for inter-reader variation and
then repeated by the ﬁrst reader for intra-reader variation. Bland-Altman
plots were utilized to assess potential systematic biases within the intra-
reader and inter-reader repeated measurements.
3. Results
The Sections 3.1–3.5 summarize the cross-sectional study results.
3.1. General Characteristics of Participants
RS adipose tissue volume ranged from 0.07 cm3 to 11.23 cm3. Indi-
viduals with fatty kidney had a higher BMI, higher level of serum KIM-
1, FGF-21 and TG levels, as well as signiﬁcantly lower LDLC level
(Table 1). However, WC and BMI adjusted binary logistic regression
shows that serum TG level is positively associatedwith IP adipose tissue
segment volume (effect size 56%, p b 0.01). In general males had signif-
icantly greater (p b 0.05)WC and higher visceral adipose tissue (RP and
IP) accumulation. However, amount of SC adipose tissue is signiﬁcantly
higher in females. These results are in agreement with those reported
previously. Concerning to the inﬂammatory cytokine levels there are
no signiﬁcant difference between control and fatty kidney group
(Table 1). Participant's eGFREPI cyst&crea was N60 ml/min/1.73 m2
(Table 1).
3.2. Abdominal Adipose Tissue Measurements
Abdominal adipose tissue compartments measured in full volumet-
ric measurement along kidney (Fig. 2a, A-1) and three-slices (Fig. 2a, A-
2) at the level of renal hilum, showed strong Pearson correlation coefﬁ-
cients for both males (RPfull and RPthree-slices, r= 0.93; IPfull and IPthree-
slices, r = 0.91; SCfull and SCthree-slices, r = 0.83; p b 0.001) and females
(RPfull and RPthree-slices, r = 0.95; IPfull and IPthree-slices, r = 0.98; SCfull
and SCthree-slices, r = 0.98; p b 0.001) participants. The results suggest,
that three slice abdominal adipose tissue measurements at the level of
the right renal hilum (Fig. 2a, A-1) completely represent IP, RP and SC
adipose tissue relative quantity at the kidney region (Fig. 2f). Addition-
ally, since RS is connected with a perinephric space only at the level of a
renal hilum then for further data analysis three sliced abdominal adi-
pose tissuemeasurements are used. Three- slice abdominal adipose tis-
sue compartment volumes are given in Table 1.
3.3. Kidney Size Measurements
Table 2 shows that females kidney (left and right) volumes are sig-
niﬁcantly (p b 0.001) lower than males. For both genders no signiﬁcant
differences between the right and left kidney volume are found. Howev-
er, for both males and females right kidney shows signiﬁcant higher
sagittal diameter and signiﬁcant lower lateral diameter compared to
the left kidney (Table 2). Consequently, the left kidney is slightly later-
ally ﬂattened which is compensated with a sagittal diameter increase.
Table 1
General characteristics of cross-sectional study participants and abdominal adipose tissue
measurements (ntotal = 280).
Measurements
Control
(no fatty kidney)
n = 199
(F/M; 96/103)
Fatty kidney
n = 81
(F/M; 44/37)
Age and
gender
adjusted
p
Anthropometric parameters
Age, yearsa 38.00 (34.00, 40.25) 38.00 (35.00, 40.00) 0.116
BMI, kg/m2 27.02 (23.98, 30.89) 30.86 (26.86, 33.35) 0.005
WC, cm 92.00 (82.00, 101.00) 100.00 (89.00, 105.00) 0.322
SBP, mm Hg 120.00 (110.00, 125.00) 120.00 (115.00, 129.00) 0.136
DBP, mm Hg 75.00 (70.00, 85.00) 80.00 (75.00, 85.00) 0.110
Adipose tissue measurements
RP, cm3 27.56 (13.33, 54.86) 52.37 (31.89, 84.53) 0.175
IP, cm3 89.81 (40.94, 168.23) 171.61 (92.50, 253.49) 0.204
SC, cm3 175.41 (111.55, 309.66) 249.26 (144.34, 340.68) 0.731
RSRight, cm3 0.39 (0.10, 0.95) 2.72 (1.83, 4.89) b0.001
Right RSRatio 0.0026 (0.0007, 0.0061) 0.0165 (0.0102, 0.0288) b0.001
RSLeft, cm3 1.42 (0.57, 2.56) 5.20 (4.28, 7.47) b0.001
Left RS Ratio 0.0084 (0.0035, 0.0148) 0.0329 (0.0258, 0.0464) b0.001
Kidney biochemical parameters
sKIM-1, pg/ml 110.10 (52.21, 235.14) 178.26 (115.25, 304.26) b0.05
FGF21, pg/ml 106.92 (66.59, 189.40) 204.26 (76.89, 404.26) b0.05
eGFREPI cyst&crea,
ml/min/1.73 m2
144.25 (108.37, 121.66) 110.39 (105.25, 119.04) 0.202
Cystatin C, mg/lb 0.69 (0.61, 0.77) 0.74 (0.63, 0.81) 0.200
Creatinine, μmol/lb 0.76 (0.68, 0.87) 0.80 (0.74, 0.96) 0.251
Glucose and lipid proﬁle
Glucose, mmol/l 5.00 (4.77, 5.35) 5.10 (4.80, 5.37) 0.171
TG, mmol/l 1.06 (0.78, 1.51) 1.47 (0.88, 1.94) b0.05
HDLC, mmol/l 1.52 (1.29, 1.77) 1.43 (1.09, 1.72) 0.190
LDLC, mmol/l 3.27 (2.79, 3.95) 2.93 (2.44, 3.78) 0.017
Inﬂammatory cytokine levels
IL-6, pg/ml 1.41 (1.09, 1.77) 1.21 (0.89, 1.52) 0.275
TNFα, pg/ml 2.32 (1.69, 3.74) 2.41 (1.94, 3.44) 0.343
Data are presented as median (25th, 75 percentile) (age and gender adjusted p values cal-
culated by binary logistic regression). BMI - body mass index; WC - Waist circumference;
SBP - systolic blood pressure; DBP - diastolic blood pressure; SC – subcutaneous adipose tis-
sue; IP– intraperitoneal adipose tissue; RP – retroperitoneal adipose tissue; RS – renal sinus
adipose tissue; RSRatio - ratio of RS adipose tissue volume to corresponding total kidney size;
sKIM-1 – serum kidney injury molecule-1; FGF-21 – ﬁbroblast growth factor – 21; eGFREPI
cyst&crea – estimated glomerular ﬁltration rate; TG – triglycerides; HDLC – high density
lipoprotein cholesterol; LDLC - low density lipoprotein cholesterol; IL-6 – interleukin 6;
TNFα - tumor necrosis factor alpha. The level of signiﬁcance was set as p b 0.05.
a Data show the gender adjusted p value.
b Serum cystatin and creatinine were used to estimate GFR.
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Anatomically, RS adipose tissue can be described as diffuse structure
which in a “drop-like” manner is situated between other structures in
the RS (Fig. 2d and f). RS adipose tissue volumes in the left and the
right kidneywere 2.7 (1.49 to 4.62) cm3 and 1.07 (0.46 to 2.45) cm3, re-
spectively, in males and 1.39 (0.57 to 2.99) cm3 and 0.39 (0.10 to 0.95)
cm3, respectively, in females participants.RS adipose tissue volumeTable 2
A kidney length (pole to pole) in the coronal plane, sagittal and lateral diameter in the axial pl
Side Male p, R vs
Kidney lenght, cm Right 10.48 ± 1.29 0.452
Left 10.89 ± 1.56
Sagittal diameter, cm Right 5.52 ± 0.68 b0.001
Left 5.15 ± 0.52
Lateral diameter, cm Right 5.24 ± 0.67 b0.001
Left 5.59 ± 0.67
Kidney volume, cm3 Right 174.96 ± 25.96 0.268
Left 177.51 ± 27.94
Median (25th, 75percentile) for skeweddata;Meanwith standarddeviation (±SD) for normally di
(normally distributeddata) andWilcoxon rank-sum test (skeweddata);Male (M) and female (F) gshows no signiﬁcant (p N 0.05) correlation corresponding to respective
(right or left) kidney volume for neither gender. However, to be able to
effectively compare females and males RS adipose tissue, as well as to
exclude the possibility that in some cases kidney volume could affect
RS adipose tissue volume, further cross-sectional study data analysis
and interpretation is done by using relative ratio - RS adipose tissue vol-
ume corresponding to kidneys (right or left) volume.
All participants (n= 280) regardless of gender, accumulate signiﬁ-
cantly more (p b 0.001) adipose tissue in the left RS (Fig. 3). Additional-
ly, the same asymmetric distribution pattern of adipose tissue we ﬁnd
for participants with high normal blood pressure (Supplemental mate-
rial Table S1.) and patients with bilateral nephrolithiasis (Supplemental
material Table S2.). Moreover, both participants with the high normal
blood pressure in comparison to the participants with the optimal
blood pressure and patientswith bilateral nephrolithiasis in comparison
to the asymptomatic participants show statistically higher adipose tis-
sue accumulation both in the left and the right RS (Supplemental mate-
rial Tables S1 and S2.).
Age and gender adjusted correlations of RS ratiowith adipositymea-
sures and continuous covariates are presented in Table 3.
RS ratio was correlated with all of the adipose tissue and anthropo-
metric measurements covariates examined (p b 0.001) except SBP and
DBP (p N 0.05), with the strongest correlations observed for other RP ad-
ipose tissue measures. Only sKIM-1 and FGF-21 was correlated with RS
ratio according to the kidney biochemical parameters (p b 0.05). Addi-
tionally, RS ratio increase was associated with an increased TG level
and decreased LDLH level. Concerning to the inﬂammatory cytokine
levels neither left RS ratio nor right RS ratio showed signiﬁcant associa-
tion with inﬂammatory cytokine levels. It is possible that smaller adi-
pose tissue compartments, like the RS adipose tissue one, could be
devoid of systemic inﬂammatory effects.
Intra-(Fig. 4a) and inter-(Fig. 4b) reader reproducibility of RS adi-
pose tissuemeasurement are shown in the Bland-Altman plots. Overall,
the mean difference between the repeated measurements was
0.001 cm2 with upper and lower conﬁdence limits of 0.442 cm2 and
−0.430 cm2, respectively, suggestingminimal systematic bias between
the intra-readermeasurements. For the inter-reader measurements the
mean difference between repeated measures was 0.005 cm2, with
upper and lower conﬁdence limits of 0.481 cm2 and−0.497 cm2. Linear
multiple regression analysis shows that there is no proportional bias in
intra-(p = 0.49) or inter-reader (p = 0.71) measurements.
3.5. RS Adipose Tissue Association With Serum KIM-1 and FGF-21 Level
sKIM-1 and FGF-21 levels were signiﬁcantly higher for the fatty kid-
ney group compared to the control group (Table 1). After grouping of
study participants into three groups according to left (Fig. 5a and c) or
right (Fig. 5b and d) RS ratio quartiles sKIM-1 and FGF-21 levels were
signiﬁcantly (p b 0.05) higher in the Q4 (N75th) quartile group for
both males and females.
We also performed an age and gender adjusted stepwise multivari-
able linear regression analysis using sKIM-1 or FGF-21 level as aane, and a kidney volume.
. L Female p, R vs. L p, M vs. F
10.50 ± 1.65 0.321 0.921
10.56 ± 1.29 0.845
5.51 ± 0.55 b0.001 0.973
5.03 ± 0.53 0.174
4.77 ± 0.61 0.002 b0.001
4.92 ± 0.55 b0.001
151.19 (137.70, 169.88) 0.175 b0.001
151.34 (134.61, 167.59) b0.001
stributeddata. The left (L) and the right (R) kidney is comparedbyusingpairedStudent's t test
roups are comparedbyusingMann-WhitneyU test. The level of signiﬁcancewas set as pb 0.05.
Fig. 3. Gender and topography (right and left kidney) effects on the renal sinus adipose
tissue accumulation. ***, ### p b 0.001; ++p = 0.006, °labels potential extremes. Right
and left kidney compared by using Wilcoxon rank-sum test; Male and female groups
compared by using Mann-Whitney test. Symbols used in the graph: *Right RS ratio vs.
Left RS ratio (for male and female group, respectively); #Female right RS ratio vs. Male
right RS ratio; +Female left RS ratio vs. Male left RS ratio. RSRatio - ratio of RS adipose
tissue volume to corresponding total kidney size.
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well as BMI and WC as predictors. The signiﬁcant association between
sKIM-1 level and right RS ratio was lost (β = 0.06; p = 0.750) but
there remained a persistent association between the left RS ratio andTable 3
Age and gender adjusted partial Pearson correlations (r) with sqrt-transformed left or
right RS ratio.
sqrt right RS ratio sqrt left RS ratio
r p r p
Anthropometric parameters
Agea 0.30 b0.001 0.32 b0.001
BMI, kg/m2 0.37 b0.001 0.36 b0.001
WC, cm 0.40 b0.001 0.36 b0.001
SBP, mm Hg 0.12 0.213 0.13 0.104
DBP, mm Hg 0.17 0.088 0.15 0.114
Adipose tissue measurements
sqrt RP,cm3 0.60 b0.001 0.52 b0.001
sqrt IP,cm3 0.50 b0.001 0.42 b0.001
sqrt SC, cm3 0.40 b0.001 0.35 b0.001
Kidney biochemical parameters
eGFREPI cyst&crea, ml/min/1.73 m2 −0.10 0.451 −0.17 0.330
Cystatin C, mg/l 0.12 0.221 0.13 0.193
Creatinine, μmol/l 0.02 0.856 0.04 0.703
Sqrt sKIM-1, pg/ml 0.49 0.040 0.56 0.023
Sqrt FGF21, pg/ml 0.57 0.001 0.64 b0.001
Glucose and lipid proﬁle
Glucose, mmol/l 0.03 0.897 0.06 0.717
Sqrt TG, mmol/l 0.25 0.009 0.21 0.033
Sqrt HDLC, mmol/l −0.04 0.688 −0.05 0.626
Sqrt LDLC, mmol/l −0.22 0.024 −0.20 0.038
Inﬂammatory cytokine levels
Sqrt IL-6, pg/ml −0.25 0.107 −0.05 0.734
Sqrt TNFα, pg/ml −0.10 0.541 −0.12 0.450
sqrt – square root-transformation; RS – renal sinus; SC – subcutaneous adipose tissue; IP –
intraperitoneal adipose tissue; RP – retroperitoneal adipose tissue; RSRatio - ratio of RS
adipose tissue volume to corresponding total kidney size; BMI – body mass index; WC –
waist circumference; SBP - systolic blood pressure; DBP – diastolic blood pressure; eGFREPI
cyst&crea – estimated glomerular ﬁltration rate; sKIM-1 – serum kidney injury molecule-1;
FGF-21 – ﬁbroblast growth factor – 21; TG – triglycerides; HDLC – high density lipoprotein
cholesterol; LDLC - low density lipoprotein cholesterol; IL-6 – interleukin 6; TNFα - tumor
necrosis factor alpha. The level of signiﬁcance was set as p b 0.05.
a Data show the gender adjusted partial Pearson correlation.
Fig. 4. Bland and Altman plots of the intra-reader (a) and the inter-reader (b) renal sinus
adipose tissue volume measurements. The average of the repeated measurements is
presented on the x-axis and the difference between two measurements is presented on
y-axis. The middle continuous line represents the mean difference between the
repeated measures, upper and lower dotted lines represent upper and lower conﬁdence
limits for the mean difference, respectively (n = 150 (M/F, 75/75)). The level of
signiﬁcance was set as p b 0.05.sKIM-1 level for both males (β = 0.43; 95% CI (0.19 to 0.65); R2 =
29%; p = 0.009) and females (β= 0.38; 95% CI (0.15 to 0.47); R2 =
26%; p = 0.023). Signiﬁcant association between sKIM-1 level and ab-
dominal adipose tissue segments (IP, RP and SC), BMI and WC were
not found. Signiﬁcant positive association between FGF-21 level and
left RS ratio + RP adipose tissue was found for both males (β= 0.56;
95% CI (0.29 to 0.72); R2 = 30%; p = 0.009) and females (β= 0.61;
95% CI (0.24 to 0.77); R2 = 34%; p = 0.023). Additionally, eGFREPI
cyst&crea negatively predicts FGF-21 concentration inmultiple regression
analyses (β=−0.31; 95% CI (0.11 to 0.54); R2 = 34%; p = 0.023) for
both genders (FGF-21 level as a dependent variable and eGFREPI cyst&crea
as well as cystatin C and creatinine as predictors). There was no collin-
earity between independent variables: VIF b 5 and tolerance N0.2.
3.6. Follow-up Study Results
There was no statistically signiﬁcant beneﬁt of text messaging inter-
vention in obese participants. Table 4 represents general characteristics,
abdominal adipose tissue measurements, FGF-21 and sKIM-1 levels for
males and females at the baseline and the end of the follow-up study
(age and gender adjusted p values were not signiﬁcant (p N 0.05) –
data not shown in the Table 4).
Main results of the one year follow-up study show that, compared to
the control group, signiﬁcant (N5%) increase in total amount of visceral
adipose tissue also induce signiﬁcant (p b 0.05) increase in amount of
adipose tissue in the left (Fig. 6a) or the right (Fig. 6b) RS. However,
when signiﬁcant (N5%) decrease in total amount of visceral adipose tis-
sue is observed, there is not signiﬁcant (p N 0.05) decrease in amount of
Fig. 5. Serum KIM-1 and FGF-21 levels according to left (a and c) or right (b and d) RS ratio quartiles. Male (M) and female (F) were divided into 3 groups based on left or right RS ratio
quartiles: b25th quartile Q1 (F/M; 34/38); 25th–75th inter quartile range Q2+Q3 (F/M; 62/60); N75th quartile Q4 (F/M; 44/42). *Q1 vs. Q4; #Q2+Q3 vs. Q4; ^Q1 vs. Q2+Q3. *, #, ^p b 0.05;
⁎⁎p b 0.01; Mann-Whitney U test.
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right and the left RS adipose tissue are positively associated with viscer-
al adipose tissue amount (Table 5).
The aim of the follow-up study was to conﬁrm the cross-sectional
study data: whether sKIM-1 and FGF-21 levels are associated with the
change of RS adipose tissue or abdominal adipose tissue amount. There-
fore, we calculated percentage change from baseline for all the adipose
tissue segments (ΔSC,ΔIP,ΔRP,Δleft RS andΔright RS adipose tissue) as
well as for sKIM-1 and FGF-21 level (ΔsKIM-1 andΔFGF-21). RS adiposeTable 4
General characteristics of follow-up study participants and abdominal adipose tissue measurem
Measurements
Intervention (text message)
Baseline End
n = 20 n = 20
BMI, kg/m2 35.68 ± 4.31 33.24 ± 3.51
WC, cm 107.52 ± 11.37 103.30 ± 9.14
RP, cm3 76.50 ± 35.02 74.78 ± 34.89
IP, cm3 245.94 ± 75.90 238.44 ± 74.66
SC, cm3 300.05 ± 132.99 280.56 ± 112.77
Left RS, cm3 3.56 (2.96, 6.95) 3.33 (2.78, 6.37)
Right RS, cm3 3.07 (1.00, 4.56) 2.83 (1.24, 4.65)
sKIM-1, pg/ml 150.37 (69.39, 290.96) 137.61 (47.67, 238
FGF-21, pg/ml 198.41 (160.32, 475.06) 177.25 (132.14, 41
Median (25th, 75 percentile) for skewed data; Mean with standard deviation (±SD) for norma
adipose tissue; IP – intraperitoneal adipose tissue; RP – retroperitoneal adipose tissue; Left RS-
kidney injury molecule-1; FGF-21 - ﬁbroblast growth factor-21.tissue volume shows no signiﬁcant (p N 0.05) correlation with the cor-
responding (right or left) kidney volume for neither gender in the
cross-sectional study, therefore, RS adipose tissue volumes were taken
for analysis. ΔsKIM-1 shows signiﬁcant positive Spearman correlation
with the Δleft and the Δright RS adipose tissue. Accordingly, both the
cross-sectional and the one year follow-up study indicates positive as-
sociation between sKIM-1 level and increase in amount of adipose tis-
sue in the renal sinus. The abdominal adipose tissue segments (ΔSC,
ΔIP, ΔRP) did not show signiﬁcant association with change in ΔsKIM-ents (ntotal = 40).
No intervention
Baseline End
n = 20 n = 20
35.86 ± 6.88 34.77 ± 7.37
106.71 ± 12.58 102.04 ± 13.82
75.01 ± 30.15 74.51 ± 28.69
244.45 ± 69.91 231.06 ± 77.76
333.42 ± 174.61 275.88 ± 120.27
3.50 (1.25, 4.09) 3.65 (1.03, 4.01)
3.33 (0.39, 2.62) 2.40 (0.37, 3.11)
.83) 159.54 (43.41, 197.10) 147.91 (56.26, 184.13)
2.11) 209.52 (176.12, 499.27) 180.33 (143.17, 398.19)
lly distributed data. BMI - body mass index; WC - waist circumference; SC – subcutaneous
left renal sinus adipose tissue; Right RS – right renal sinus adipose tissue; sKIM-1 – serum
Fig. 6. Left (a) and right (b) renal sinus adipose tissue volumes changes (%) in the one year
follow-up period, based on the visceral adipose tissue signiﬁcant (N5%) increase or
decrease. The mean value of the time point “Baseline” was arbitrarily set at 100%. p
Value shown above the black, blue and red lines represent difference between
“Baseline” and “End” (Wilcoxon rank-sum test). p Value which are indicated under the
brace represent difference between control group (Mann Whitney U test). The level of
signiﬁcance was set as p b 0.05.
281G. Krievina et al. / EBioMedicine 13 (2016) 274–2831 serum level (Table 6). ΔFGF-21shows signiﬁcant positive Spearman
correlation with the Δleft RS and RP adipose tissue amount. These re-
sults also conﬁrms cross-sectional study results.
4. Discussion
To the best of our knowledge ﬁndings reported in this study add
some aspects to the function of RS adipose tissue. First, results indicate
asymmetrical deposition of adipose tissue into the RS even after corre-
spondingkidney volume adjustment in bothmales and females. Second,Table 5
Age and gender adjusted partial Person correlations (r) between the left and the right renal sin
Visceral adipose tissue Baseline, cm3
Right RS Baseline, cm3 0.82⁎⁎⁎
Left RS Baseline, cm3 0.79⁎⁎⁎
Right RS End, cm3
Left RS End, cm3
ΔRight RS, %
ΔLeft RS, %
Δ – percentage change from baseline; Left RS - left renal sinus adipose tissue; Right RS – right
⁎⁎⁎ p b 0.001.the cross-sectional and the follow-up studies shows that sKIM-1 level is
positively associated with RS adipose tissue volume increase for both
genders. Third, FGF-21 is associated with RS and RP adipose tissue
amount and shows inverse association with GFR. Fourth, follow up
study shows that accumulation of adipose tissue in the RS is related
with the visceral adipose tissue volume increase. Additionally, signiﬁ-
cant visceral adipose tissue volume increase is related with signiﬁcant
increase of adipose tissue amount in the RS. However, signiﬁcant
visceral adipose tissue volume decrease does not show signiﬁcant de-
crease of adipose tissue amount in the RS. From this we can draw a hy-
pothesis that the RS adipose tissue accumulation happens faster than
elimination.
Interestingly, that the left RS accumulate signiﬁcantly more adipose
tissue than the right RS for both genders. Moreover, we did not ﬁnd as-
sociation between kidney size and RS adipose tissue volume. To the best
of our knowledge, this anatomical phenomenon previously has not
been described. One of the reason could be, that since the object seg-
mentation and 3D reconstruction of RS adipose tissue compartment is
labor-intensive and time-consuming, often chosen strategy is CT or
MR single slice cross-sectional area measurement at a speciﬁc anatomic
level (Foster et al., 2011a; Chughtai et al., 2010; Wagner et al., 2012) or
RS adipose tissue volume detection only in one kidney (Foster et al.,
2011a; Foster et al., 2011b). Thiswaydata processing time is signiﬁcant-
ly optimized, however, this also results in loss of measurement quality.
Based on the results can be said that the RS adipose tissue compart-
ments are a diffuse object that have “drop-like” form and are located be-
tween major and minor renal calices. Therefore, using only one scan
could lead to inaccurate result that does not represent total amount of
adipose tissue in the RS. Also fact that normal humans have two kid-
neys, therefore, two RS, must be taken into account whenmakingmea-
surements. Since humans are not bilaterally symmetrical (especially
when talking about abdominal organs) and kidneys have both function-
al aswell as anatomical asymmetry described, then it is important to an-
alyze both RS.
We speculate that, ﬁrst, asymmetrical RS adipose tissue accumula-
tion could be result of anatomical differences between left and right
renal vein. The right renal vein receives blood only from the right kid-
ney, but the left renal vein receives left gonadal and adrenal veins in ad-
dition to the vein coming from the left kidney (Anjamrooz et al., 2012).
There is no difference in diameter between the left and the right renal
vein (Satyapal et al., 1995) but possibly this asymmetry predispose
the left RS for higher RS adipose tissue deposition. Second, there is
wide variation in calyceal orientation (Miller et al., 2013) According to
theKaye andReinke results (Kaye andReinke, 1984), the calyceal angles
in the right and the left kidney differs.
The concept of anatomical, physiological, and functional asymmetry
between kidneys has been amatter of interest for researchers. Clinicians
recommend that functional asymmetry of the kidneys should be inves-
tigated preoperatively to determine which kidney should be donated
and transplanted (Salehipour et al., 2008). Although, we did not ﬁnd in-
formation about asymmetric RS deposition, considerable differences in
renal blood ﬂow have been reported between the right and the left kid-
neys in some previous investigations. VanOnna and co-authors showed
that asymmetry of renal blood ﬂow was present in up to 51% ofus adipose tissue and visceral adipose tissue in the one year follow-up study (ntotal = 40).
Visceral adipose tissue End, cm3 ΔVisceral adipose tissue, %
0.76⁎⁎⁎
0.78⁎⁎⁎
0.65⁎⁎⁎
0.71⁎⁎⁎
renal sinus adipose tissue.
Table 6
Spearman correlations between percentage change from baseline for the all adipose tissue
segments (ΔSC, ΔIP, ΔRP, Δleft RS and Δright RS adipose tissue), sKIM-1 (ΔsKIM-1) and
FGF-21 (ΔFGF-21) level.
ΔsKIM-1, % ΔFGF-21, %
ΔRP,% r 0.19 0.61
p 0.609 0.002
ΔIP,% r 0.21 0.14
p 0.510 0.110
ΔSC, % r 0.16 0.14
p 0.667 0.091
ΔLeft RS,% r 0.69 0.47
p 0.031 0.044
ΔRight RS, % r 0.61 0.36
p 0.039 0.051
Δ – percentage change from baseline; SC – subcutaneous adipose tissue; IP – intraperito-
neal adipose tissue; RP – retroperitoneal adipose tissue; Left RS - left renal sinus adipose
tissue; Right RS – right renal sinus adipose tissue; sKIM-1 – serum kidney injury mole-
cule-1; FGF-21 – ﬁbroblast growth factor-21. The level of signiﬁcance was set as p b 0.05.
282 G. Krievina et al. / EBioMedicine 13 (2016) 274–283hypertensive patients. Moreover, mean left renal blood ﬂowwas on av-
erage signiﬁcantly lower than the right mean renal blood ﬂow (van
Onna et al., 2002). Similar, Caralps et al. reported that in 10 out of 11
asymmetry cases the left kidney was more affected than the right one
(Caralps et al., 1974). Van Onna and co-authors showed that there is
no association between kidney volume and asymmetry of renal blood
ﬂow in their study subjects (van Onna et al., 2002). We hypothesized
that signiﬁcant higher RS adipose tissue deposition in the left kidney
possibly could be inborn structural phenomenon that might cause
asymmetrical renal blood ﬂow.
Results of this study show that sKIM-1 level is positively associated
with the RS adipose tissue volume increase for both males and females.
In normal kidney proximal tubules KIM-1 are expressed at a very low
level (Ichimura et al., 2004). However, its expression is signiﬁcantly in-
creased in the post-ischemic kidney (Ichimura et al., 1998). Jin and co-
authors in their study detected sKIM-1 level (126.2 ± 53.5 pg/ml) for
healthymiddle age control subjects (Jin et al., 2013). Our study showed
comparable average sKIM-1 concentrations for females andmales in RS
ratio quartile Q1 (63.56 (41.67 to 98.11) pg/ml and 79.20 (41.67 to
111.55) pg/ml, respectively). However, signiﬁcant sKIM-1 level increase
in the RS ratio quartile Q4 was observed.We propose that one of the ini-
tial mechanisms for obesity-induced renal damage and hypertension
could be linked to proximal convoluted tubule epithelial cell damage
caused by RS adipose tissue produced compression of intrarenal
collecting system, blood and lymph vessel. As the left RS accumulate sig-
niﬁcantlymore adipose tissues than the right RS, possibly, early changes
could be observed directly in the left kidney. Together these ﬁndings in-
dicate that there is some structural and functional asymmetry between
deposition of adipose tissue in the right and the left RS.
In agreement with other studies (Stein et al., 2009; Zhang et al.,
2015; Lee et al., 2015) serum levels of the FGF-21 depend on renal func-
tions because renal elimination is a major route by which physiological
FGF-21 serum levels are maintained. Like other researches (Stein et al.,
2009; Lee et al., 2015) we found that GFR is signiﬁcantly and inversely
associated with circulating FGF-21 level. Furthermore, the cross-sec-
tional and follow-up study conﬁrms that FGF-21 level was positively as-
sociated with the RS and RP adipose tissue amount. We hypothesized
that this association could be due to brown adipose tissue accumulation,
respectively, RS and RP adipose tissues has differentmorphological pro-
ﬁle compared with the IP and SC adipose tissues. Brown adipose tissue
presence in the perirenal adipose tissue compartment was conﬁrmed
with biopsies from healthy kidney donors (Svensson et al., 2014) and
with a positron emission tomography/CT investigations (Nedergaard
et al., 2007). Ouellet et al. conﬁrmed brown adipose tissue presence in
perirenal fat compartment in a large cohort of patients (n = 4842)
(Ouellet et al., 2011). Another research onmice suggested that perirenal
adipose tissue compartment contains a mixture of brown and whiteadipose tissue (Fisher et al., 2012). Accumulation of brown adipose tis-
sue in RS could induce compression of various renal structures de-
scribed before (Montani et al., 2004; Foster et al., 2011b; Chughtai et
al., 2010). However, effect of brown adipose tissue on serum lipoprotein
level could be favorable. This is consistent with our data because fatty
kidney group showed signiﬁcantly lower LDLC level. Bartelt et al. iden-
tiﬁed brown adipose tissue as a major organ involved in plasma very
light density lipoprotein triglycerides clearance in mice. Cold exposure
activated brown adipose tissue signiﬁcantly lowered level of TG. How-
ever, HDLC level slightly increased, which is probably explained by an
increase of TG-rich lipoproteins derived HDLC precursors. For further
studieswe have to detect serum level of uncoupling protein-1 – amark-
er of brown adipose tissue.
Our study has limitations. First, we analyzed only serum KIM-1.
There are studies that reﬂect serum KIM-1 as blood marker for
early kidney injury detection as mentioned before, however, detec-
tion of urine KIM-1 could give more precise results. Second, relative-
ly small number of individuals were included in the follow-up study.
Strengths of our study are that volumetric analysis of various adipose
tissue segments was carried out. Amount of adipose tissue in the RS
was standardized by using corresponding kidney, thus excluding
possibility that size of the kidney inﬂuence amount of adipose tissue
in the RS. Moreover, our results show that it is important to measure
the left and the right RS adipose tissue volumes because of signiﬁcant
asymmetrical RS adipose tissue deposition. The research group was
selected so that both genders and all BMI groups were evenly
represented.
Regardless of gender adipose tissue in RS accumulates asymmetri-
cally – the left RS accumulates a signiﬁcantly higher amount of adipose
tissue. Thus, primarily RS adipose tissue effects should be assessed on
the left kidney. Accumulation of adipose tissue in the RS is related
with the visceral adipose amount and KIM-1 concentration increase in
the blood serum. Additionally, FGF-21 level is positively associated
with the RS and RP adipose tissue amount.Funding
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